Pregnancy in β-thalassemia trait carriers: An uneventful journey

Hematology

Volumn 14, Issue 5, 2009, Pages 301-303

  Tsatalas, Constantinos ^a   Chalkia, Panagiota ^b   Pantelidou, Despoina ^b   Margaritis, Dimitrios ^a   Bourikas, Georgios ^a   Spanoudakis, Emmanouil ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b AHEPA University Hospital   (Greece)

Author keywords

thalassemia trait; Anemia; Pregnancy

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

BETA THALASSEMIA; DRUG EFFICACY; ERYTHROCYTE VOLUME; FETUS RISK; GENETIC TRAIT; GESTATIONAL AGE; HETEROZYGOSITY; HUMAN; INHERITANCE; NEURAL TUBE DEFECT; NORMOCHROMIC NORMOCYTIC ANEMIA; PLASMA VOLUME; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SHORT SURVEY;

ANEMIA, HYPOCHROMIC; BETA-THALASSEMIA; ERYTHROCYTE VOLUME; FEMALE; HUMANS; PLASMA VOLUME; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; QUANTITATIVE TRAIT LOCI;

EID: 71049159521     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X439791     Document Type: Short Survey

References (33)

1. Weatherall DJ, Clegg JB. The thalassemia syndromes, 3rd edn. Oxford: Blackwell Scientific Publications, 1981.
2. Williams JL. Anemias of abnormal globin development-thalassemias. In: Stiene-Martin EA, Lotspeich-Steininger CA, Koepke JA. (eds) Clinical hematology, 2nd edn. Philadelphia, PA: Lippincott, 1998; 217-240.
3. Rappaport VJ, Velazquez M, Williams K. Hemoglobinopathies in pregnancy. Obstet Gynecol Clin North Am 2004; 31: 287-317.
4. Malamos B, Fessas P, Stamatoyannopoulos G. Types of thalassemia-trait carriers as revealed by a study of their incidence in Greece. Br J Haematol 1962; 8: 5-14.
5. Hytten F. Blood volume changes in normal pregnancy. Clin Hematol 1985; 14: 601-612.
6. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann NY Acad Sci 2000; 900: 125-136.
7. Letsky EA. Erythropoiesisinpregnancy. J Perinat Med 1995;23:39-45.
8. World Health Organization. Nutritional anaemias. Tech Rep Ser 1972, 503.
9. CDC criteria for anemia in children and child-bearing-aged women. MMWR Morb Mortal Wkly Rep 1989; 38: 400-404.
10. Olivieri N, Weatherall DJ. Clinical aspects of β-thalassemia. In: Steinberg LM, Forge BE, Higgs DR, Nagel RL. (eds) Disorders of hemoglobin; genetics, pathophysiology and clinical management. Cambridge: Cambridge University Press, 2001; 277-341.
11. Chalkia P, Tsatalas C, Tsantali C et al. Change in erythropoiesis with gestational age during pregnancy in β-thalassemic women. The Haematology Journal 2002; 3(Suppl 1): 75.
12. Bianco I, Mastropietro F, D'Asero C et al.: Serum levels of erythropoietin and soluble transferrin receptor during pregnancy in non-β-thalassemic and β-thalssemic women. Haematologica 2000, 85, 902-907.
13. Schuman JE, Tanser CL, Péloquin R et al. The erythropoietic response to pregnancy in β-thalassemia minor. Br J Haematol 1973; 25: 249-260.
14. Fleming AF, Lynch W. Beta-Thalassemia minor during pregnancy with particular reference to iron status. J Obstet Gynaecol Brit Commonw 1969; 76: 451-457.
15. Mc Cullough JC, Kelly AM. Investigation of pregnancy-related changes in red cell 2,3 Diphosphoglycerate. Clin Chim Acta 1979; 98: 235-241.
16. Poole JH. Thalassemia and pregnancy. J Perinat Neonat Nurs 2003; 17: 196-208.
17. Tassiopoulos TH, Kaltsoya-Tassiopoulos A, Alchanati N et al. Anémie, 2,3-DPG et oxygénation tissulaire chez les hétérozygotes de β-thalassémie. Nouv Rev Fr Hématol 1982; 24: 359-362.
18. Fessas PH, Tassiopoulos TH. Erythropoiesis and anemia in heterozygous β-thalassaemia. Br J Haematol 1987; 67: 245-246.
19. Hegde UM, Khunda S, Marsh GW et al. Thalassaemia, iron and pregnancy. Br Med J 1975; 3: 509-511.
20. Pakes JB, Cooperberg AA, Gelfand MM. Studies on beta thalassemia trait in pregnancy. Amer J Obstet Gynecol 1970; 108: 1217-1223.
21. Alger LS, Golbus MS, Laros RK. Thalassemia and pregnancy: results of an antenatal screening program. Am J Obstet Gynecol 1979; 134: 662-673.
22. White JM, Richards R, Byrne M et al. Thalassaemia trait and pregnancy. J Clin Pathol 1985; 38: 810-817.
23. Sheiner E, Levy A, Yerushalmi R et al. Beta-thalassemia minor during pregnancy. Obstet Gynecol 2004; 103: 1273-1277.
24. ACOG Committee on Obstetrics. ACOG Practice Bulletin Nu 78: hemoglobinopathies in pregnancy.Obstet Gynecol 2007; 109: 229-237.
25. Junca J, Vela D, Orts M et al. Treating the anaemia of a pregnancy with heterozygous beta thalassaemia with recombinant human erythropoietin (r-HU EPO). Eur J Haematol 1995; 55: 277-278.
26. Breymann C, Fibach E, Visca E et al. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. J Matern Fetal Med 1999; 8: 1-7.
27. Bencaiova G, Krafft A, Burkhardt T et al. Variable efficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy. Acta Haematol 2006; 116: 259-265.
28. Epoetin-alpha SPC. Available from: http://emc.medicines.org.uk/ (accessed 2008 July).
29. Kaltsoya-Tassiopoulou A, Loutradi-Anagnostou A, Rompos J et al. Hematological and biochemical parameters in pregnancy. Comparison between normal controls and heterozygous β-thalassemia. Iatriki (in Greek) 1983; 43: 40-48.
30. Ratten GJ, Beischer NA. The significance of anaemia in an obstetric population in Australia. J Obstet Gynaecol Brit Commonw 1972; 79: 228-237.
31. Economidou J, Augustaki O, Georgiopoulou H et al. Assessment of iron stores in subjects heterozygous for β-thalassaemia on serum ferritin levels. Acta Haematol 1980; 64: 205-208.
32. Ibba RM, Zoppi MA, Floris M et al. Neural tube defects in the offspring of thalassemia carriers. Fetal Diagn Ther 2003; 18: 5-7.
33. Locksmith GJ, Duff P. Preventing neural tube defects: the importance of periconceptional folic acid supplements. Obstet Gynecol 1998; 9: 1027-1034.